{
  "docId": "019dd923-5e88-73ef-bd5d-01cf0d8a8fbc",
  "docSlug": "cc8183ec02431b7a",
  "documentTitle": "2022 Air Street Capital The State of AI Report 2022",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 64,
  "pageCount": 114,
  "prevPage": 63,
  "nextPage": 65,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The slide uses a combination of narrative text and two charts to illustrate the 'physical bottlenecks' of drug development.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bar_chart_vertical",
    "bar_chart_vertical"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc/64",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-01cf0d8a8fbc#slide-64",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "While AI promises better drugs faster, we need to solve for the physical bottlenecks of clinical trials today.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a21d-648ec30aae1a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.55,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Stepwise probability of drug success",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "05043353-76a2-432e-887b-97af162bf586",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.4,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "chart",
      "text": "# of registered studies (ClinicalTrials.gov EOY)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12fcba82-4cbc-48a8-bf93-613afabcc244",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Clinical trial duration: 10.5 years",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c4-7719-a21d-69196686da2d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.9,
        "x": 0.05,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "A study of 6,151 successful phase transitions between 2011–2020 found that it takes 10.5 years on average for a drug to achieve regulatory approval. This includes 2.3 years at Phase I, 3.6 years at Phase II, 3.3 years at Phase III, and 1.3 years at the regulatory stage. What’s more, it costs $6.5k on average to recruit one patient into a clinical trial. With 30% of patients eventually dropping out due to non-compliance, the fully-loaded recruitment cost is closer to $19.5k/patient. While AI promises better drugs faster, we need to solve for the physical bottlenecks of clinical trials today.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ededab55-f9ae-4da9-ac71-873d1803dc3d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "Can AI and compute bend the physical reality of clinical trial chokepoints?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f24dadf-c394-4207-bb93-37c50e47aadf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "56805467-429d-4917-aba5-5452c8e9a4fc",
      "evidence": "The slide mentions 'Can AI and compute bend the physical reality of clinical trial chokepoints?' implying a before-after comparison.",
      "confidence": 0.7
    },
    {
      "name": "Curiosity Gap",
      "slug": "curiosity-gap",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "019dd95a-1055-74e0-a956-63463183666f",
      "evidence": "Title 'Can AI and compute bend the physical reality of clinical trial chokepoints?' poses question.",
      "confidence": 75
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 80,
      "from": 5,
      "beatId": "019dd95a-0682-776c-8e35-2557e3799e96",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Definitions, exec summary, Research and Industry sections inventory the state of AI.",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 93,
      "from": 11,
      "beatId": "019dd95a-0682-776c-8e35-35abf646aa8b",
      "arcName": "The Mountain",
      "arcSlug": "mountain",
      "beatName": "Rising Action",
      "beatSlug": "mountain-rising-action",
      "evidence": "Research, Industry, Politics sections accumulate signals.",
      "position": 2,
      "confidence": 55,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 69,
      "from": 62,
      "name": "Pattern Hunter",
      "slug": "02-pattern-hunter",
      "bestFor": "Time-pressed audiences, building consensus, when data is strong",
      "matchId": "019dd95a-07fe-70ce-8d3d-c1bcbf6f888c",
      "evidence": "Copilot, AI-first drug pipelines, CE-mark imaging, UK university spinouts, Stanford/Berkeley programmes.",
      "position": 11,
      "objective": "Inventory commercial AI applications: code, drug discovery, diagnostics, spinouts",
      "structure": "Evidence A -> Evidence B -> Evidence C -> Pattern/Conclusion",
      "confidence": 72,
      "description": "Group multiple pieces of evidence that together point to a pattern or conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}